A five-factor risk-stratification model for cancer-associated myositis in idiopathic inflammatory myopathies and stage-specific survival analysis: a multicentre Japanese MYKO cohort study.

Oe K, Matsuda S, Akiyama C, Yamamoto M, Suzuka T, Nakashima R, Tsuji H, Sasai T, Nohda Y, Yoshida T, Nakayama Y, Nakakubo Y, Ogawa A, Yoshida K, Hirobe K, Aitani Y, Koshida Y, Miyake H, Takeuchi T, Kotani T

Open source

DOI: 10.3389/fimmu.2026.1914962
Published: 2026
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1914962,
  title = {A five-factor risk-stratification model for cancer-associated myositis in idiopathic inflammatory myopathies and stage-specific survival analysis: a multicentre Japanese MYKO cohort study.},
  author = {Oe K and Matsuda S and Akiyama C and Yamamoto M and Suzuka T and Nakashima R and Tsuji H and Sasai T and Nohda Y and Yoshida T and Nakayama Y and Nakakubo Y and Ogawa A and Yoshida K and Hirobe K and Aitani Y and Koshida Y and Miyake H and Takeuchi T and Kotani T},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1914962},
  url = {https://doi.org/10.3389/fimmu.2026.1914962}
}

RIS

TY  - JOUR
TI  - A five-factor risk-stratification model for cancer-associated myositis in idiopathic inflammatory myopathies and stage-specific survival analysis: a multicentre Japanese MYKO cohort study.
AU  - Oe K
AU  - Matsuda S
AU  - Akiyama C
AU  - Yamamoto M
AU  - Suzuka T
AU  - Nakashima R
AU  - Tsuji H
AU  - Sasai T
AU  - Nohda Y
AU  - Yoshida T
AU  - Nakayama Y
AU  - Nakakubo Y
AU  - Ogawa A
AU  - Yoshida K
AU  - Hirobe K
AU  - Aitani Y
AU  - Koshida Y
AU  - Miyake H
AU  - Takeuchi T
AU  - Kotani T
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1914962
UR  - https://doi.org/10.3389/fimmu.2026.1914962
ER  -

APA

K, O., S, M., C, A., M, Y., T, S., R, N., H, T., T, S., Y, N., T, Y., Y, N., Y, N., A, O., K, Y., K, H., Y, A., Y, K., H, M., T, T., & T, K. (2026). A five-factor risk-stratification model for cancer-associated myositis in idiopathic inflammatory myopathies and stage-specific survival analysis: a multicentre Japanese MYKO cohort study.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1914962

Source records

pubmed · retrieved 2026-09-26T02:22:55.263Z